Taken together, this is the first study to simultaneously quantify tau protein isoforms, non-phosphorylated and phosphorylated tau protein in both TBS and SI fractions from different tauopathies, specifically AD, PSP, CBD, and PiD, and control cases. Here, MAPT is linked to Alzheimer disease.